Berlin’s Cultimate Foods is winding down, leaving cultivated-fat’s boldest thesis quietly defunct.

The first: 80 Acres Farms, the Ohio vertical-farming unicorn that raised nearly $400 million over a decade, announced a nationwide wind-down after a buyer walked away at the eleventh hour. The second: Marc Lore’s Wonder just closed a $650 million round at a ~$9 billion valuation, with JPMorgan, Goldman, and Jefferies reportedly prepping a 2027 IPO.

One sector’s decade-old leader collapsing overnight. Another’s brash newcomer pulling in the largest food-tech cheque of the summer. And buried between them, two more quiet deaths — Berlin’s Cultimate Foods winding down its cultivated-fat thesis, and the broader cultivated-meat funding pool sitting at roughly a twentieth of its 2021 peak.

So what’s the throughline? I think it’s this: the food-tech categories that promised to reinvent production from the inside out — vertical farms, cultivated meat, cultivated fat — are hitting the same brick wall their critics always warned about. Unit economics at scale. Tens or hundreds of millions of capital burned before the cost curve catches up to the romance.

Meanwhile, the bets that are still getting funded look different. Wonder is vertically integrated, automation-heavy, and built around a real restaurant unit — not a bioreactor. Abbott and Google’s new partnership pushes continuous glucose monitoring out of the clinic and into the wellness subscription aisle. Imperial College just engineered lettuce and tobacco to produce animal myoglobin in the field, not the vat — potentially giving plant-based meat its heme fix at agricultural cost rather than fermentation cost. And Malaysia’s Khazanah-linked Xeraya just backed Australian precision-fermentation startup All G, validating infant-formula-grade dairy proteins as the most defensible near-term wedge for the sector.

The pattern, if there is one: capital is migrating away from “rewrite how food is grown” toward “rewrite how food reaches you, how it’s personalised, and which proteins are high-margin enough to ferment profitably right now.” The promise hasn’t died — but the geography of who gets to keep building has shifted, fast, over a single summer.

Here’s what stood out this morning — six developments worth your attention, and what they tell us about where food tech is actually headed.

Today’s Headlines

I’ll search multiple queries in parallel to get broad coverage of recent food tech news.Good initial results. Let me dig deeper on a few of these specific leads with follow-up research.I have strong material. Let me get one more search to flesh out the plant molecular farming story and confirm key dates.I have everything I need. Here’s the digest:

Food Tech News Digest (Aug 11–12, 2026)

1. Wonder raises $650M at a ~$9B valuation, eyeing 2027 IPO

• URL: https://alleywatch.com/2026/08/us-startup-funding-top-largest-july-2026-vc/
• Source: AlleyWatch / MarketScale
• Summary: Marc Lore’s AI-driven mealtime platform Wonder closed a $650M round led by Accel, Google Ventures, and NEA, with ARK Invest and AllianceBernstein joining. The capital fuels expansion to ~140 locations, deeper integration of Sweetgreen’s Infinite Kitchen robotics, Zipline drone delivery, and “Wonder Create” virtual-restaurant branding — with banks (JPMorgan, Goldman, Jefferies) reportedly prepping a 2027 IPO. ^1
• Why it matters: It’s the largest food-tech funding event of the summer and signals that investors are betting on vertically-integrated, automation-heavy restaurant platforms over standalone ghost kitchens.

2. 80 Acres Farms abruptly shuts down after acquisition collapses

• URL: https://www.cincinnati.com/story/money/2026/08/05/why-did-80-acres-farms-close-ohio-kentucky-news-update/91175281007
• Source: Cincinnati Enquirer / Local12 / San Antonio Report
• Summary: Ohio-based vertical farming unicorn 80 Acres Farms announced a nationwide wind-down on Aug 3 after a prospective buyer walked away on Aug 2, leaving no path to continued funding. WARN notices indicate ~145 layoffs in Hamilton, 166 in San Antonio, 110 in Forest Park GA, and 73 in Anderson SC — affecting supply to retailers like H-E-B and Kroger, and unwinding the 2025 Soli Organic merger that had formed a 1,400-employee network. ^2
• Why it matters: A decade-old, $390M-funded category leader collapsing overnight is the strongest signal yet that the indoor/vertical farming sector’s unit economics still don’t pencil out at scale.

3. Cultimate Foods (Berlin) winds down — another cultivated-meat closure

• URL: https://www.greenqueen.com.hk/cultimate-foods-lab-grown-cultivated-meat-fat-startup-bankruptcy-closure
• Source: Green Queen
• Summary: Berlin-based Cultimate Foods, which raised €2.3M in 2024 to commercialise its CultiSense cell-cultured fat ingredient, halted operations in 2026 after filing for insolvency in April, citing inability to secure further capital. The closure joins a growing 2025–2026 list (Believer Meats, Meatable, Uncommon Bio’s exit) as sector funding fell to ~$74M in 2025 — roughly 1/20th of the 2021 peak. ^3
• Why it matters: Cultivated fat was supposed to be the “easier” wedge into the cultivated-meat market; its failure suggests even the trimmed-down thesis is struggling to attract capital.

4. Abbott × Google Health: Lingo CGM meets AI health coaching

• URL: https://abbott.mediaroom.com/2026-08-11-Abbott-and-Google-launch-first-of-its-kind-partnership-to-transform-everyday-health-through-glucose-insights-and-AI
• Source: Abbott press release / Fierce Biotech / Android Authority
• Summary: Announced Aug 11, the multiyear deal integrates Abbott’s Lingo consumer continuous glucose monitor data into the Google Health app, with Google Health Coach delivering AI-personalised nutrition/activity/sleep guidance. The partnership also launches one of the largest real-world metabolic health studies to date, combining CGM data with wearables, labs and surveys; full consumer rollout is expected later in 2026 (Health Coach runs $10/mo or $100/yr). ^4
• Why it matters: It’s the first major tech-platform endorsement of consumer CGM for non-diabetics — pushing metabolic monitoring from a clinical device into a mainstream wellness/subscription product.

5. Imperial College engineers tobacco & lettuce to produce animal myoglobin

• URL: https://www.imperial.ac.uk/news/articles/natural-sciences/life-sciences/2026/lettuce-and-tobacco-plants-engineered-to-produce-muscle-protein-for-meat-alternatives
• Source: Imperial College London / Frontiers in Plant Science
• Summary: Published Aug 6 in Frontiers in Plant Science, Dr. Alexia Groff’s team used a “gene gun” to insert pig/cattle myoglobin genes into the chloroplasts of tobacco and lettuce — the first stable production of an animal muscle protein in higher plants. Yields hit ~800 mg myoglobin per kg dry weight (~3× higher than nuclear-genome insertion), the trait was seed-heritable, and the work was backed by the Bezos Centre for Sustainable Protein and startup Kyomei Ltd. ^5
• Why it matters: Plant molecular farming could give plant-based meat the heme-driven colour and umami of real muscle at agricultural — not bioreactor — scale, side-stepping the cost ceiling that’s stalling cultivated meat.

6. All G secures Xeraya (Khazanah-linked) backing for precision-fermented dairy

• URL: https://www.greenqueen.com.hk/all-g-precision-fermentation-lactoferrin-funding-xeraya-capital-khazanah-malaysia
• Source: Green Queen
• Summary: Australian precision-fermentation startup All G — producing bioidentical bovine and human milk proteins (notably lactoferrin and human beta-casein for infant formula) — received new funding from Xeraya Capital, a fund manager linked to Malaysia’s Khazanah, bringing total raised past $36M as it gears toward a Series B. The startup also landed a A$1.1M NSW government biosciences grant to scale human beta-casein. ^6
• Why it matters: Sovereign-wealth-linked capital flowing into precision-fermented dairy proteins validates the infant-formula and high-value-ingredient thesis as the most defensible near-term wedge for precision fermentation.

Want me to save this as a markdown digest in your workspace, or send it to Telegram/email?

Final Thoughts

The Wrap

Today’s stories trace a clear arc: capital is concentrating on a few capital-intensive winners (Wonder’s $650M, Abbott × Google) while the long-tail ofnext-food thesis companies — vertical farms, cultivated meat — continue to fall away as unit economics fail to clear. Plant molecular farming and precision-fermented dairy are emerging as the more tractable paths to bio-based protein, trading bioreactor complexity for agricultural or ingredient-wedge scale.

What this signals for the industry is a sharper bifurcation: investor money is now backing either proven automation-led restaurant economics (Wonder) or defensible high-ingredient-value biotech (All G’s infant-formula proteins, Imperial’s myoglobin lettuce) rather than moonshot standalone categories. The consumer-metabolic layer (CGM + AI coaching) is quietly becoming the bridge that connects both ends to mainstream wallets.

What to watch next: Wonder’s confirmed 2027 IPO timeline and any follow-on closures in the cultivated-meat sector through year-end.

Over to you: Which of today’s developments do you think will most shape food tech’s next 12 months — Wonder’s IPO push, the CGM-goes-mainstream deal, or the molecular-farming breakout? Hit reply and let us know what you’re watching.

Compiled from industry sources. All credits and links provided above.